Breakwater Capital Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Sell
6,937
-853
-11% -$46.3K 0.04% 313
2026
Q1
$489K Hold
7,790
0.07% 241
2025
Q4
$743K Hold
7,790
0.1% 182
2025
Q3
$761K Sell
7,790
-28
-0.4% -$2.9K 0.11% 174
2025
Q2
$840K Sell
7,818
-69
-0.9% -$6.98K 0.14% 157
2025
Q1
$796K Buy
7,887
+221
+3% +$22.3K 0.14% 144
2024
Q4
$685K Sell
7,666
-14
-0.2% -$1.23K 0.14% 151
2024
Q3
$644K Buy
7,680
+15
+0.2% +$1.18K 0.13% 154
2024
Q2
$590K Buy
7,665
+376
+5% +$27.5K 0.13% 150
2024
Q1
$499K Buy
7,289
+303
+4% +$19.5K 0.13% 157
2023
Q4
$424K Buy
6,986
+537
+8% +$28.7K 0.12% 157
2023
Q3
$333K Buy
6,449
+632
+11% +$33.1K 0.11% 162
2023
Q2
$315K Buy
5,817
+431
+8% +$22.5K 0.12% 161
2023
Q1
$269K Buy
5,386
+1,053
+24% +$49.6K 0.11% 152
2022
Q4
$200K Buy
+4,333
New +$188K 0.1% 165

Other funds holding BSX

Breakwater Capital Group's BSX Position: Q2 2026 in Review

Breakwater Capital Group reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $46.3K and leaving 6,937 shares worth $296K. The position accounts for 0.04% of the portfolio, ranked #313.

Breakwater Capital Group first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $840K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Breakwater Capital Group held 6,937 shares of Boston Scientific worth $296K as of Q2 2026.
  • Breakwater Capital Group sold 853 Boston Scientific shares in Q2 2026, an estimated $46.3K.
  • Boston Scientific made up 0.04% of Breakwater Capital Group's portfolio in Q2 2026, its #313 holding.
  • Breakwater Capital Group first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Breakwater Capital Group's Boston Scientific position peaked at $840K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.